Werewolf Therapeutics Shares Jump on Encouraging Trial Data
By Dean Seal Shares of Werewolf Therapeutics shot higher after the company presented Phase 1 trial data establishing proof of mechanism for its lead clinical...
Source: marketwatch.com
Stay updated with breaking news from Executive Daniel Hicklin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
By Dean Seal Shares of Werewolf Therapeutics shot higher after the company presented Phase 1 trial data establishing proof of mechanism for its lead clinical...